Anatol Kreitzer

About Anatol Kreitzer

Anatol Kreitzer is a chief discovery officer at MapLight Therapeutics.

Anatol Kreitzer reports to the SEC as an officer of 1 public company.

Anatol Kreitzer first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Anatol Kreitzer in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Anatol Kreitzer works with at each company, as listed on that company's latest Form D.

Sources

1. SECMapLight Therapeutics, Inc. Form D, filed Jul 28, 2025
2. SECForms 3, 4 and 5 filed by Anatol Kreitzer (SEC filer 2021238)